Viewing Study NCT05757869


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2025-12-30 @ 6:56 AM
Study NCT ID: NCT05757869
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2023-02-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module